We are live on
!
Find out more
BCM
Brown Capital Management Portfolio holdings
AUM
$500M
1-Year Est. Return
25.3%
This Fund
S&P 500
This Quarter
Est. Return
-2.25%
1 Year Est. Return
+25.3%
3 Year Est. Return
+79.24%
5 Year Est. Return
+57.49%
10 Year Est. Return
+614.96%
AUM
$10.3B
AUM Growth
-$237M
(-2.3%)
Cap. Flow
+$163M
Cap. Flow
% of AUM
1.58%
Top 10 Holdings %
Top 10 Hldgs %
43.82%
Holding
123
New
3
Increased
50
Reduced
44
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Glaukos
GKOS
|
+$137M |
| 2 |
iRhythm Holdings
IRTC
|
+$85M |
| 3 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$61.7M |
| 4 |
ABMD
Abiomed Inc
ABMD
|
+$57.9M |
| 5 |
AppFolio
APPF
|
+$57.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDSO
Medidata Solutions, Inc.
MDSO
|
+$125M |
| 2 |
Blackbaud
BLKB
|
+$69.1M |
| 3 |
Paycom
PAYC
|
+$62.4M |
| 4 |
ACI Worldwide
ACIW
|
+$28.4M |
| 5 |
Manhattan Associates
MANH
|
+$25.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 50.29% |
| 2 | Healthcare | 31.84% |
| 3 | Industrials | 10.41% |
| 4 | Materials | 3.63% |
| 5 | Consumer Discretionary | 0.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Veeva Systems
VEEV
$33.8B
| $531M | 5.16% |
3,479,648
-10,700
| -0.3% | -$1.72M |
|
2
Tyler Technologies
TYL
$13.7B
| $525M | 5.1% |
2,000,507
-16,626
| -0.8% | -$4.07M |
|
|
3
Manhattan Associates
MANH
$12.1B
| $484M | 4.69% |
5,996,097
-315,600
| -5% | -$25.3M |
|
|
4
Paycom
PAYC
$7.88B
| $471M | 4.57% |
2,248,945
-266,892
| -11% | -$62.4M |
|
5
Cognex
CGNX
$9.62B
| $466M | 4.52% |
9,483,237
+6,431
| +0.1% | +$290K |
|
6
Neogen
NEOG
$2.05B
| $460M | 4.46% |
13,506,528
+340,858
| +3% | +$11.8M |
|
|
ANSS
7
DELISTED
Ansys
ANSS
| $401M | 3.89% |
1,811,346
-800
| -0% | -$168K |
|
|
AYX
8
DELISTED
Alteryx Inc
AYX
| $395M | 3.83% |
3,677,439
-90,451
| -2% | -$11.2M |
|
9
Guidewire Software
GWRE
$13.9B
| $393M | 3.81% |
3,728,624
-1,810
| -0% | -$182K |
|
|
PRO
10
DELISTED
PROS Holdings
PRO
| $390M | 3.78% |
6,541,603
+62,549
| +1% | +$4.21M |
|
11
Protolabs
PRLB
$1.7B
| $386M | 3.75% |
3,784,878
+17,352
| +0.5% | +$1.77M |
|
|
BCPC
12
Balchem Corp
BCPC
$5.26B
| $372M | 3.61% |
3,748,903
-54,990
| -1% | -$5.24M |
|
13
QuidelOrtho
QDEL
$1.13B
| $346M | 3.36% |
5,647,014
-1,400
| -0% | -$84.2K |
|
14
Q2 Holdings
QTWO
$3.78B
| $329M | 3.19% |
4,165,239
+161,533
| +4% | +$13.4M |
|
|
15
Blackbaud
BLKB
$1.94B
| $328M | 3.19% |
3,636,093
-777,208
| -18% | -$69.1M |
|
16
Bio-Techne
TECH
$11.2B
| $321M | 3.11% |
6,554,188
-1,600
| -0% | -$80.2K |
|
|
CMD
17
DELISTED
Cantel Medical Corporation
CMD
| $293M | 2.84% |
3,919,478
-2,148
| -0.1% | -$182K |
|
|
ABMD
18
DELISTED
Abiomed Inc
ABMD
| $289M | 2.81% |
1,626,542
+268,066
| +20% | +$57.9M |
|
|
19
Glaukos
GKOS
$9.49B
| $285M | 2.77% |
4,565,244
+1,946,782
| +74% | +$137M |
|
|
CSII
20
DELISTED
Cardiovascular Systems, Inc.
CSII
| $279M | 2.71% |
5,877,227
+1,313,875
| +29% | +$61.7M |
|
|
21
iRhythm Holdings
IRTC
$4.02B
| $246M | 2.38% |
3,315,104
+1,097,259
| +49% | +$85M |
|
|
MDSO
22
DELISTED
Medidata Solutions, Inc.
MDSO
| $235M | 2.28% |
2,565,359
-1,370,299
| -35% | -$125M |
|
23
Helios Technologies
HLIO
$2.47B
| $234M | 2.27% |
5,775,282
| – | – |
|
24
Alarm.com
ALRM
$2.75B
| $221M | 2.14% |
4,730,792
+242,186
| +5% | +$11.9M |
|
25
Inogen
INGN
$174M
| $177M | 1.72% |
3,703,773
+56,446
| +2% | +$2.94M |
|
Similar funds
H2CM
CWM
MIP
AGP
HSG
DAC
AA
MCCP
Brown Capital Management's Q3 2019 Portfolio in Review
As of Q3 2019, Brown Capital Management held 123 positions worth $10.3B, down 2.3% from $10.5B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Trading was light in Q3 2019: portfolio turnover was 4.1%. Brown Capital Management opened 3 new positions and exited 2, leaving the 123-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 50% of assets, up from 50% a quarter earlier, followed by Healthcare and Industrials.
- Brown Capital Management's largest Q3 2019 buy was Charles River Laboratories: 6,062 shares worth $802K.
- Brown Capital Management added most to Glaukos in Q3 2019, an estimated $137M increase.
- Brown Capital Management's biggest Q3 2019 reduction was Medidata Solutions, Inc., cutting an estimated $125M.
- Brown Capital Management fully exited Sasol in Q3 2019, selling an estimated $9.82M.
- Brown Capital Management's ten largest holdings make up 44% of its $10.3B portfolio in Q3 2019.
- Brown Capital Management opened 3 new positions and closed 2 in Q3 2019.
- Brown Capital Management's portfolio value fell 2.3% quarter-over-quarter to $10.3B.
Based on Brown Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.